Immatics (IMTX) Shares Outstanding (Weighted Average) (2019 - 2025)

Immatics recorded quarterly Shares Outstanding (Weighted Average) of $156.1 million in Q4 2025, up 10978245.92% quarter-over-quarter from $1421.6 in Q3 2025, and up 20.15% year-over-year from $129.9 million in Q4 2024.

Immatics' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $156.1 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Weighted Average) rose 20.15% year-over-year to $156.1 million; the TTM figure through Dec 2025 stood at $156.1 million (up 20.15% YoY), while the FY2025 annual figure was $151.5 million, up 16.62% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $156.1 million for Q4 2025 at Immatics, up from $1421.6 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q1 2025 to a low of $10.86 in Q1 2024.
  • A 5-year average of $181.1 million and a median of $70.3 million in 2021 frame the typical range for Shares Outstanding (Weighted Average).
  • Across the five-year window, Shares Outstanding (Weighted Average) sank 100.0% in 2024 and surged 11774083977.95% in 2025, its largest moves.
  • Immatics' Shares Outstanding (Weighted Average) stood at $72.0 million in 2021, then slipped by 4.71% to $68.6 million in 2022, then gained by 26.36% to $86.7 million in 2023, then surged by 49.88% to $129.9 million in 2024, then increased by 20.15% to $156.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $156.1 million, $1421.6, and $1030.1 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 177,333.76 Bn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 185,491.37 Bn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 100.00 Bn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 55.66 Bn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 254.10 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - 16.04 Bn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 132.89 Mn
10 Immatics 1.80 Bn 1.80 Bn - 156.06 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 156.06 Mn
Sep 30, 2025 1,421.57
Jun 30, 2025 1,030.08
Mar 31, 2025 1.28 Bn
Dec 31, 2024 129.89 Mn
Sep 30, 2024 43.93
Jun 30, 2024 1.11 Mn
Mar 31, 2024 10.86
Dec 31, 2023 86.66 Mn
Sep 30, 2023 90.77 Mn
Jun 30, 2023 631,576.15
Mar 31, 2023 823.25 Mn
Dec 31, 2022 68.58 Mn
Sep 30, 2022 66.18 Mn
Jun 30, 2022 696.79 Mn
Mar 31, 2022 1,526.38
Dec 31, 2021 71.97 Mn
Sep 30, 2021 74.19 Mn
Jun 30, 2021 939.33
Mar 31, 2021 75.88 Mn
Dec 31, 2020 57.23 Mn
Sep 30, 2020 73.48 Mn
Jun 30, 2020 980,299.52
Mar 31, 2020 36.53 Mn
Dec 31, 2019 36.63 Mn
Sep 30, 2019 36.82 Mn
Jun 30, 2019 1.31 Bn